Home Overview Press Room Blog Publications For Students about us
Search

Biotech & Pharma : Displaying 747-756 of 2371


Should We Open the Door to Genetically Modified Babies?by Jessica CussinsCNBCAugust 11th, 2014There has been a lot of confusion around this controversial issue, but as we are now facing a historic crossroads, it is important to set the record straight.
Over-Optimistic Portrayal of Life-Supporting Treatments in Newspapers and Internetby Thaddeus PopeMedical Futility BlogAugust 9th, 2014Newspapers and the Internet have the potential to influence patients' knowledge and attitudes toward medical decision-making by providing over-optimistic medical information.
Tuskegee Todayby Jessica CussinsThe Huffington PostAugust 8th, 2014Last week marked the 42nd anniversary of the Tuskegee syphilis study and many people took the opportunity to examine its relevance to the treatment of human research subjects today.
Will my Disabled Daughter have a Place in this Genetic Wonderland?by Ian BirrellThe GuardianAugust 7th, 2014Until society gets to grips with prejudice we cannot start to grapple with the profound questions that medical advances raise.
Tuskegee, Todayby Jessica CussinsBiopolitical TimesAugust 7th, 2014Last week marked the 42nd anniversary of the Tuskegee syphilis study and many people took the opportunity to examine its relevance to the treatment of human research subjects today.
North Carolina and Genetics: From Sterilization to Research Subjectsby Victoria Massie, Biopolitical Times guest contributorAugust 7th, 2014In the twentieth century, North Carolina was one of dozens of states that targeted certain citizens for eugenic sterilization. Today, in a town outside Charlotte, biotech researchers are asking for urine and blood samples and offering $10 gift cards to WalMart in exchange.
Study Shows Third Gene as Indicator for Breast Cancerby Nicholas BakalarThe New York TimesAugust 6th, 2014Mutations in the gene raise risk in women by almost as much as mutations in BRCA1 and BRCA2, the genes implicated in most inherited cases.
Data Yearning to Become Expensive Informationby Pete ShanksBiopolitical TimesAugust 6th, 2014Big players have big “big data and genetics” plans afoot. Here’s the news from Genomics England, 23andMe, Google and Craig Venter.
Use of Experimental Ebola Drug Raises Red Flags Among Medical Expertsby Monte MorinLos Angeles TimesAugust 5th, 2014The FDA has authorized use of an unapproved Ebola virus test under a special emergency-use provision, although efforts to develop a vaccine for the deadly illness are unlikely to bear fruit until 2015.
Genetic Testing of Citizens: A Backdoor Into Total Population Surveillance by Governments, Companiesby Helen WallaceEpoch TimesAugust 3rd, 2014The new Chief Executive of England's National Health Service wants to make people’s personal genetic information the basis of their treatments.
Displaying 747-756 of 2371  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760